Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 9:35:42.
doi: 10.1186/s40880-016-0106-2.

Genomic alterations and molecular subtypes of gastric cancers in Asians

Xiang S Ye  1   2 , Chunping Yu  3 , Amit Aggarwal  4 , Christoph Reinhard  4
Affiliations
Review

Genomic alterations and molecular subtypes of gastric cancers in Asians

Xiang S Ye et al. Chin J Cancer. .

Abstract

Gastric cancer (GC) is a highly heterogenic disease, and it is the second leading cause of cancer death in the world. Common chemotherapies are not very effective for GC, which often presents as an advanced or metastatic disease at diagnosis. Treatment options are limited, and the prognosis for advanced GCs is poor. The landscape of genomic alterations in GCs has recently been characterized by several international cancer genome programs, including studies that focused exclusively on GCs in Asians. These studies identified major recurrent driver mutations and provided new insights into the mutational heterogeneity and genetic profiles of GCs. An analysis of gene expression data by the Asian Cancer Research Group (ACRG) further uncovered four distinct molecular subtypes with well-defined clinical features and their intersections with actionable genetic alterations to which targeted therapeutic agents are either already available or under clinical development. In this article, we review the ACRG GC project. We also discuss the implications of the genetic and molecular findings from various GC genomic studies with respect to developing more precise diagnoses and treatment approaches for GCs.

Keywords: Cancer genome; Gastric cancer; Heterogeneity; Molecular subtyping; Oncogenic drivers; Targeted therapy.

PubMed Disclaimer

References

    1. Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancers. 2013;5(1):48–63. doi: 10.3390/cancers5010048. - DOI - PMC - PubMed
    1. Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer–molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10(11):643–655. doi: 10.1038/nrclinonc.2013.170. - DOI - PMC - PubMed
    1. Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P, Li GL, et al. Report of incidence and mortality in China cancer registries, 2008. Chin J Cancer Res. 2012;24(3):171–180. doi: 10.1007/s11670-012-0171-2. - DOI - PMC - PubMed
    1. Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, et al. Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol. 2011;17(39):4421–4428. doi: 10.3748/wjg.v17.i39.4421. - DOI - PMC - PubMed
    1. Chen W, Zheng R, Zeng H, Zhang S. The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer. 2015;34(11):502–507. - PMC - PubMed